Kurt Bestehorn

Summary

Affiliation: Technical University
Country: Germany

Publications

  1. ncbi Characteristics, management and attainment of lipid target levels in diabetic and cardiac patients enrolled in Disease Management Program versus those in routine care: LUTZ registry
    Kurt Bestehorn
    Medical Department, MSD Sharp and Dohme GmbH, Haar, Germany
    BMC Public Health 9:280. 2009
  2. ncbi Stroke risk screening of adults with hypertension: prospective cross-sectional study in primary care
    Kurt Bestehorn
    Institute for Clinical Pharmacology, Medical Faculty Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
    Clin Drug Investig 28:281-9. 2008
  3. ncbi Contemporary trends in cardiac rehabilitation in Germany: patient characteristics, drug treatment, and risk-factor management from 2000 to 2005
    Kurt Bestehorn
    Medical Department, MSD Sharp and Dohme GmbH, Haar, Germany
    Eur J Cardiovasc Prev Rehabil 15:312-8. 2008
  4. ncbi Dual cholesterol inhibition with ezetimibe/simvastatin in pre-treated hypercholesterolaemic patients with coronary heart disease or diabetes mellitus: prospective observational cohort studies in clinical practice
    Steven K Hildemann
    Essex pharma, Medical Department, Munich, Germany
    Curr Med Res Opin 23:713-9. 2007
  5. ncbi Current state of cardiac rehabilitation in Germany: patient characteristics, risk factor management and control status, by education level
    Kurt Bestehorn
    Institute for Clinical Pharmacology, Technical University, Dresden, Germany
    Vasc Health Risk Manag 7:639-47. 2011
  6. ncbi [Medical registries]
    Kurt Bestehorn
    Institut fur Klinische Pharmakologie, Forschungsverbund Public Health Sachsen und Sachsen Anhalt, Medizinische Fakultät Carl Gustav Carus, Technische Universitat Dresden, Dresden
    Med Klin (Munich) 100:722-8. 2005
  7. ncbi [Registries for clinical trials -- a critical stock-taking]
    Kurt Bestehorn
    Institut fur Klinische Pharmakologie, Medizinische Fakultät Carl Gustav Carus, Technische Universitat, Dresden
    Med Klin (Munich) 101:120-6. 2006
  8. ncbi Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care
    Kurt Bestehorn
    Institute for Clinical Pharmacology, Public Health Association Saxony, Technical University Dresden, Germany
    Curr Med Res Opin 26:2833-9. 2010
  9. ncbi Drug utilization of ezetimibe in rehabilitation centres: registry analysis of factors influencing prescription and effectiveness of treatment
    Kurt Bestehorn
    MSD Sharp and Dohme, Haar, Germany
    Curr Med Res Opin 22:631-9. 2006
  10. ncbi Management of high-risk patients with hypertension and left ventricular hypertrophy in Germany: differences between cardiac specialists in the inpatient and outpatient setting
    Heinz Völler
    Klinik am See, Seestrasse 84, D 15562 Rüdersdorf bei Berlin, Germany
    BMC Public Health 6:256. 2006

Detail Information

Publications15

  1. ncbi Characteristics, management and attainment of lipid target levels in diabetic and cardiac patients enrolled in Disease Management Program versus those in routine care: LUTZ registry
    Kurt Bestehorn
    Medical Department, MSD Sharp and Dohme GmbH, Haar, Germany
    BMC Public Health 9:280. 2009
    ..Little is known about the characteristics, treatment and target attainment lipid levels of these patients enrolled in DMPs compared to patients in routine care (non-DMP)...
  2. ncbi Stroke risk screening of adults with hypertension: prospective cross-sectional study in primary care
    Kurt Bestehorn
    Institute for Clinical Pharmacology, Medical Faculty Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
    Clin Drug Investig 28:281-9. 2008
    ..We therefore aimed to assess the risk factor profile of hypertensive patients in primary care in various age groups, and to calculate their corresponding risk of stroke...
  3. ncbi Contemporary trends in cardiac rehabilitation in Germany: patient characteristics, drug treatment, and risk-factor management from 2000 to 2005
    Kurt Bestehorn
    Medical Department, MSD Sharp and Dohme GmbH, Haar, Germany
    Eur J Cardiovasc Prev Rehabil 15:312-8. 2008
    ..We aimed to describe temporal trends and centre variances of patient characteristics, drug prescriptions, and risk-factor management of in-patients in inpatient CR in Germany...
  4. ncbi Dual cholesterol inhibition with ezetimibe/simvastatin in pre-treated hypercholesterolaemic patients with coronary heart disease or diabetes mellitus: prospective observational cohort studies in clinical practice
    Steven K Hildemann
    Essex pharma, Medical Department, Munich, Germany
    Curr Med Res Opin 23:713-9. 2007
    ..6 mmol/L) low density cholesterol (LDL-C) cholesterol threshold in the primary care setting...
  5. ncbi Current state of cardiac rehabilitation in Germany: patient characteristics, risk factor management and control status, by education level
    Kurt Bestehorn
    Institute for Clinical Pharmacology, Technical University, Dresden, Germany
    Vasc Health Risk Manag 7:639-47. 2011
    ....
  6. ncbi [Medical registries]
    Kurt Bestehorn
    Institut fur Klinische Pharmakologie, Forschungsverbund Public Health Sachsen und Sachsen Anhalt, Medizinische Fakultät Carl Gustav Carus, Technische Universitat Dresden, Dresden
    Med Klin (Munich) 100:722-8. 2005
    ..The methodological necessities and limitations of the informational value are pointed out. CONCLUSION: Registries are able to contribute substantially to health care research...
  7. ncbi [Registries for clinical trials -- a critical stock-taking]
    Kurt Bestehorn
    Institut fur Klinische Pharmakologie, Medizinische Fakultät Carl Gustav Carus, Technische Universitat, Dresden
    Med Klin (Munich) 101:120-6. 2006
    ..A national clinical trials registry could be installed at best only complementary and would have to get its data directly from the international registry without additional burden by research facilities...
  8. ncbi Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care
    Kurt Bestehorn
    Institute for Clinical Pharmacology, Public Health Association Saxony, Technical University Dresden, Germany
    Curr Med Res Opin 26:2833-9. 2010
    ....
  9. ncbi Drug utilization of ezetimibe in rehabilitation centres: registry analysis of factors influencing prescription and effectiveness of treatment
    Kurt Bestehorn
    MSD Sharp and Dohme, Haar, Germany
    Curr Med Res Opin 22:631-9. 2006
    ..The aims of the present study were to analyse factors that influence the prescribing decisions of physicians, and to investigate success rates of lipid lowering therapy with ezetimibe after adjustment for covariates...
  10. ncbi Management of high-risk patients with hypertension and left ventricular hypertrophy in Germany: differences between cardiac specialists in the inpatient and outpatient setting
    Heinz Völler
    Klinik am See, Seestrasse 84, D 15562 Rüdersdorf bei Berlin, Germany
    BMC Public Health 6:256. 2006
    ..We aimed to investigate differences in characteristics and health care management of such patients treated as inpatients or outpatients by cardiac specialists...
  11. ncbi [Fixed-combination of losartan/hydrochlorothiazide 100 mg/25 mg. Tolerability and efficacy on blood pressure measured in the practice and for 24 hours]
    Andreas Forster
    MSD Sharp and Dohme GmbH, München Haar
    MMW Fortschr Med 149:111-8. 2007
    ..Special consideration was given to the results of ambulatory 24-hourblood pressure (ABP) measurements...
  12. ncbi Gap between guidelines and practice: attainment of treatment targets in patients with primary hypercholesterolemia starting statin therapy. Results of the 4E-Registry (Efficacy Calculation and Measurement of Cardiovascular and Cerebrovascular Events Inclu
    Gerd Assmann
    Leibniz Institute of Arteriosclerosis Research at the University of Muenster, Muenster, Germany
    Eur J Cardiovasc Prev Rehabil 13:776-83. 2006
    ..Even after 9 months, only 21.3% of men and 17.3% of women with manifest atherosclerosis reached target LDL. CONCLUSIONS: Most high-risk patients do not achieve LDL targets. Overtreatment of low-risk groups is also very common...
  13. ncbi Actual clinical practice of exercise testing in consecutive patients after non-ST-elevation myocardial infarction: results of the acute coronary syndromes registry
    Harm Wienbergen
    Heart Center Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
    Eur J Cardiovasc Prev Rehabil 13:457-63. 2006
    ..Frequency and therapeutic impact of exercise testing after non-ST-elevation myocardial infarction (NSTEMI) in actual clinical practice, however, is not known...
  14. ncbi [Return to work after cardiologic rehabilitation]
    Jacqueline Müller-Nordhorn
    Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie, Universitatsklinikum Charite, Humboldt Universitat zu Berlin
    Soz Praventivmed 48:370-8. 2003
    ..The objectives of the present study were to determine prospectively return to work and its predictors in patients after cardiac rehabilitation...
  15. ncbi [Drug therapy in postmenopausal osteoporosis. An analysis of healty service delivery]
    Kurt Bestehorn
    Medizinische Forschung MSD Sharp and Dohme GmbH, Haar
    Z Arztl Fortbild Qualitatssich 96:699-704. 2002
    ..CONCLUSION: The data reveal significant deficits in the primary care treatment of postmenopausal osteoporosis...